A positron emission tomography study to investigate peripheral benzodiazepine receptor occupancy following single oral doses of SSR180575 in healthy male subjects

Trial Profile

A positron emission tomography study to investigate peripheral benzodiazepine receptor occupancy following single oral doses of SSR180575 in healthy male subjects

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 21 Feb 2006

At a glance

  • Drugs SSR 180575 (Primary)
  • Indications Arthritis; Diabetic neuropathies; Heart failure; Neurodegenerative disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 21 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top